On March 1, 2017, Paul Braier spoke at the 6th Annual Pharma IPR 2017 conference in Mumbai, a leading forum for IP professionals from leading Indian and global pharma companies and law firms. Paul spoke about FDA’s new rules and guidances, and how they affect generic drug companies. For the third year running, G&B is a Silver Sponsor for this premier event. More information on the conference can be found here (http://www.pharmaipr-india.com/). Click here for a copy of the presentation.